Literature DB >> 19402868

Low-dose cabergoline causing valvular heart disease in a patient treated for prolactinoma.

T J Cawood, P Bridgman, L Hunter, D Cole.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19402868     DOI： 10.1111/j.1445-5994.2009.01920.x

Source DB:  PubMed          Journal:  Intern Med J        ISSN： 1444-0903            Impact factor:   2.048


× No keyword cloud information.
  7 in total

1.  Clinical management and outcome of 36 invasive prolactinomas treated with dopamine agonist.

Authors:  Moon Sool Yang; Jae Won Hong; Seung Koo Lee; Eun Jig Lee; Sun Ho Kim
Journal:  J Neurooncol       Date:  2010-11-24       Impact factor: 4.130

Review 2.  Cabergoline in acromegaly.

Authors:  Emmanuelle Kuhn; Philippe Chanson
Journal:  Pituitary       Date:  2017-02       Impact factor: 4.107

3.  Incidence of Cabergoline-Associated Valvulopathy in Primary Care Patients With Prolactinoma Using Hard Cardiac Endpoints.

Authors:  Craig Edward Stiles; Guy Lloyd; Sanjeev Bhattacharyya; Richard Paul Steeds; Kambiz Boomla; Jonathan Paul Bestwick; William Martyn Drake
Journal:  J Clin Endocrinol Metab       Date:  2021-01-23       Impact factor: 5.958

4.  Pulmonary Artery Occlusion and Mediastinal Fibrosis in a Patient on Dopamine Agonist Treatment for Hyperprolactinemia.

Authors:  Junjing Su; Ulf Simonsen; Jørn Carlsen; Soren Mellemkjaer
Journal:  Front Pharmacol       Date:  2017-07-20       Impact factor: 5.810

5.  Long-term cardiac (valvulopathy) safety of cabergoline in prolactinoma.

Authors:  Shruti Khare; Anurag R Lila; Rishikesh Patil; Milind Phadke; Prafulla Kerkar; Tushar Bandgar; Nalini S Shah
Journal:  Indian J Endocrinol Metab       Date:  2017 Jan-Feb

6.  A scoping review to understand the indications, effectiveness, and limitations of cabergoline in radiological and biochemical remission of prolactinomas.

Authors:  Rakesh Mishra; Subhas K Konar; Adesh Shrivastava; Pradeep Chouksey; Sumit Raj; Amit Agrawal
Journal:  Indian J Endocrinol Metab       Date:  2022-02-17

7.  The Third Case of Cabergoline-Associated Valvulopathy: The Value of Routine Cardiovascular Examination for Screening.

Authors:  Carmela Caputo; David Prior; Warrick J Inder
Journal:  J Endocr Soc       Date:  2018-07-11
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.